{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:32:52Z","timestamp":1793997172337,"version":"4.8.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02107","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:29:11Z","timestamp":1599143351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Marco P.","family":"La Manna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartolo","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusto D.","family":"Badami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Caccamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"B1","year":"2019","journal-title":"Global Tuberculosis Report 2019."},{"key":"B2","year":"2015","journal-title":"Stop TJUNOfPS, UNOPS, Geneva Switzerland. Partnership: The Paradigm Shift. 2016-2020. Global Plan to End TB."},{"key":"B3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/bib\/bbr005","article-title":"Literature mining, ontologies and information visualization for drug repurposing.","volume":"12","author":"Andronis","year":"2011","journal-title":"Brief Bioinform."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1080\/07391102.2019.1637280","article-title":"Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis.","volume":"38","author":"Rani","year":"2019","journal-title":"J Biomol Struct Dyn."},{"key":"B5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB.","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3129","article-title":"Setting new targets in the fight against tuberculosis.","volume":"19","author":"Raviglione","year":"2013","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1093\/infdis\/jir881","article-title":"Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.","author":"Zumla","year":"2012","journal-title":"J Infect Dis."},{"key":"B8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2174\/1381612822666160128150636","article-title":"Opportunities and challenges for host-directed therapies in tuberculosis.","volume":"22","author":"Sachan","year":"2016","journal-title":"Curr Pharm Design."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00171","article-title":"Host-directed therapeutic strategies for tuberculosis.","volume":"4","author":"Kolloli","year":"2017","journal-title":"Front Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis.","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/372691a0","article-title":"Recognition of a lipid antigen by CD1-restricted \u03b1\u03b2+ T cells.","volume":"372","author":"Beckman","year":"1994","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","article-title":"MR1 presents microbial vitamin B metabolites to MAIT cells.","volume":"491","author":"Kjer-Nielsen","year":"2012","journal-title":"Nature."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells.","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat Immunol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601399","article-title":"Type II NKT cells and their emerging role in health and disease.","volume":"198","author":"Dhodapkar","year":"2017","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1084\/jem.193.8.893","article-title":"The mouse Cd1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.","volume":"193","author":"Park","year":"2001","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1084\/jem.182.4.993","article-title":"CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.","volume":"182","author":"Cardell","year":"1995","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.7542404","article-title":"CD1-restricted T cell recognition of microbial lipoglycan antigens.","volume":"269","author":"Sieling","year":"1995","journal-title":"Science."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00594","article-title":"Targeting innate-like T cells in Tuberculosis.","volume":"7","author":"Huang","year":"2016","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.4049\/jimmunol.171.4.1961","article-title":"An anti-inflammatory role for V\u03b114 NK T cells in Mycobacterium bovis Bacillus calmette-Gu\u00e9rin-infected mice.","volume":"171","author":"Dieli","year":"2003","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.micinf.2004.01.003","article-title":"Interferon-\u03b3 production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18.","volume":"6","author":"Kawakami","year":"2004","journal-title":"Microb Infect."},{"key":"B21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/(sici)1521-4141","article-title":"Induction of IFN-\u03b3-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Gu\u00e9rin.","volume":"29","author":"Emoto","year":"1999","journal-title":"Eur J Immunol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000239","article-title":"Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria.","volume":"4","author":"Sada-Ovalle","year":"2008","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.06018-11","article-title":"Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.","volume":"80","author":"Kee","year":"2012","journal-title":"Infect Immun."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01394","article-title":"Latent Mycobacterium tuberculosis infection is associated with a higher frequency of mucosal-associated Invariant T and invariant natural killer T cells.","volume":"9","author":"Paquin-Proulx","year":"2018","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2007.12.006","article-title":"Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype.","volume":"127","author":"Montoya","year":"2008","journal-title":"Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1086\/513567","article-title":"Individuals with pulmonary Tuberculosis have lower levels of circulating CD1d-restricted NKT cells.","volume":"195","author":"Snyder-Cappione","year":"2007","journal-title":"J Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tube.2009.07.004","article-title":"High granulocyte\/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting.","volume":"89","author":"Sutherland","year":"2009","journal-title":"Tuberculosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nri2904","article-title":"Presumed guilty: natural killer T cell defects and human disease.","volume":"11","author":"Berzins","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.clim.2007.12.005","article-title":"Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections.","volume":"127","author":"Im","year":"2008","journal-title":"Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2249.2006.03144","article-title":"Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.","volume":"145","author":"Veenstra","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10875-014-0090-8","article-title":"Mycobacterium tuberculosis-specific memory NKT cells in patients with Tuberculous pleurisy.","volume":"34","author":"Li","year":"2014","journal-title":"J Clin Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tube.2014.01.005","article-title":"Programmed death-1 receptor suppresses \u03b3-IFN producing NKT cells in human tuberculosis.","volume":"94","author":"Singh","year":"2014","journal-title":"Tuberculosis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"28633","DOI":"10.18632\/oncotarget.5764","article-title":"Antigen-specific human NKT cells from tuberculosis patients produce IL-21 to help B cells for the production of immunoglobulins.","volume":"6","author":"Wu","year":"2015","journal-title":"Oncotarget."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08525","article-title":"Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model.","volume":"4","author":"Zhao","year":"2015","journal-title":"eLife."},{"key":"B35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.tube.2017.04.011","article-title":"Quantitative and qualitative iNKT repertoire associations with disease susceptibility and outcome in macaque tuberculosis infection.","volume":"105","author":"Chancellor","year":"2017","journal-title":"Tuberculosis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01126","article-title":"\u03b1-GalCer and iNKT cell-based cancer immunotherapy: realizing the therapeutic potentials.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/science.7624800","article-title":"A gene outside the human MHC related to classical HLA class I genes.","volume":"269","author":"Hashimoto","year":"1995","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells.","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1084\/jem.20130958","article-title":"Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.","volume":"210","author":"Reantragoon","year":"2013","journal-title":"J Exp Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.178.1.1","article-title":"Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.","volume":"178","author":"Porcelli","year":"1993","journal-title":"J Exp Med."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4866","article-title":"Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCR\u03b2 repertoire.","volume":"5","author":"Lepore","year":"2014","journal-title":"Nat Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1016\/j.celrep.2019.07.039","article-title":"Activation and in vivo evolution of the MAIT cell transcriptome in mice and humans reveals tissue repair functionality.","volume":"28","author":"Hinks","year":"2019","journal-title":"Cell Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/imcb.12281","article-title":"Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers.","volume":"97","author":"Kelly","year":"2019","journal-title":"Immunol Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.celrep.2019.08.050","article-title":"TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions.","volume":"28","author":"Leng","year":"2019","journal-title":"Cell Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/cei.12277","article-title":"Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.","volume":"176","author":"Serriari","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12506","article-title":"Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.","volume":"7","author":"Meermeier","year":"2016","journal-title":"Nature Commun."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24476","article-title":"Functionally diverse human T cells recognize non-microbial antigens presented by MR1.","volume":"6","author":"Lepore","year":"2017","journal-title":"eLife."},{"key":"B48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.exger.2013.11.003","article-title":"Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.","volume":"49","author":"Lee","year":"2014","journal-title":"Exp Gerontol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coi.2006.07.001","article-title":"CD1d- and MR1-restricted invariant T cells: of mice and men.","volume":"18","author":"Treiner","year":"2006","journal-title":"Curr Opin Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","article-title":"Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17\u2013secreting T cells.","volume":"117","author":"Dusseaux","year":"2011","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.4049\/jimmunol.176.3.1618","article-title":"MR1-restricted V\u03b119 mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.","volume":"176","author":"Kawachi","year":"2006","journal-title":"J Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1073\/pnas.0914839107","article-title":"Analysis of CD161 expression on human CD8 T cells defines a distinct functional subset with tissue-homing properties.","volume":"107","author":"Billerbeck","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4143","article-title":"Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development.","volume":"5","author":"Leeansyah","year":"2014","journal-title":"Nat Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/ni.1890","article-title":"Antimicrobial activity of mucosal-associated invariant T cells.","volume":"11","author":"Le Bourhis","year":"2010","journal-title":"Nat Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/mi.2014.81","article-title":"MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets.","volume":"8","author":"Kurioka","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner.","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/eji.201445313","article-title":"IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions.","volume":"45","author":"Sattler","year":"2015","journal-title":"Eur J Immunol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005072","article-title":"Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection.","volume":"11","author":"Leeansyah","year":"2015","journal-title":"PLoS Pathog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.4049\/jimmunol.1203218","article-title":"IL-7 Licenses activation of human liver intrasinusoidal mucosal-associated invariant T Cells.","volume":"190","author":"Tang","year":"2013","journal-title":"J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/mi.2016.39","article-title":"Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.","volume":"10","author":"Chen","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86292","article-title":"Distinct activation thresholds of human conventional and innate-like memory T cells.","volume":"1","author":"Slichter","year":"2016","journal-title":"JCI Insight."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood-2011-02-334698","article-title":"Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161hi CD8\u03b1+ semi-invariant T cells.","volume":"118","author":"Turtle","year":"2011","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700615","article-title":"Activation of human mucosal-associated invariant T Cells induces CD40L-dependent maturation of monocyte-derived and primary dendritic cells.","volume":"199","author":"Salio","year":"2017","journal-title":"J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/intimm\/dxs069","article-title":"Analysis of stem-cell-like properties of human CD161++IL-18R\u03b1+ memory CD8+ T cells.","volume":"24","author":"Havenith","year":"2012","journal-title":"Int Immunol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11653","article-title":"MAIT cells are activated during human viral infections.","volume":"7","author":"van Wilgenburg","year":"2016","journal-title":"Nat Commun."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/mi.2012.45","article-title":"Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress.","volume":"6","author":"Gold","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00279-12","article-title":"Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.","volume":"80","author":"Chua","year":"2012","journal-title":"Infect Immun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/imm.12461","article-title":"High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells.","volume":"145","author":"Sharma","year":"2015","journal-title":"Immunology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jinf.2015.11.010","article-title":"Mucosal-associated invariant T cells from patients with tuberculosis exhibit impaired immune response.","volume":"72","author":"Jiang","year":"2016","journal-title":"J Infection."},{"key":"B72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tube.2015.03.004","article-title":"Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity.","volume":"95","author":"Kwon","year":"2015","journal-title":"Tuberculosis."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000407","article-title":"Human mucosal associated invariant T cells detect bacterially infected cells.","volume":"8","author":"Gold","year":"2010","journal-title":"PLoS Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1164\/rccm.201401-0106OC","article-title":"Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis.","volume":"190","author":"Jiang","year":"2014","journal-title":"Am J Respir Care Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"E3119","DOI":"10.1073\/pnas.1302799110","article-title":"MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.","volume":"110","author":"Meierovics","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4049\/jimmunol.1402545","article-title":"Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites.","volume":"195","author":"Sakala","year":"2015","journal-title":"J Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","article-title":"Unconventional T cell targets for cancer immunotherapy.","volume":"48","author":"Godfrey","year":"2018","journal-title":"Immunity."},{"key":"B78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology.","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1126\/science.1068819","article-title":"Adaptive immune response of V\u03b32V\u03b42 T cells during mycobacterial infections.","volume":"295","author":"Shen","year":"2002","journal-title":"Science."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000024353","article-title":"Antigen recognition by human \u03b3\u03b4 T lymphocytes.","volume":"122","author":"Kabelitz","year":"2000","journal-title":"Int Arch Allergy Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"\u03b3\u03b4 T cells: first line of defense and beyond.","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.953410","article-title":"Stress-related and homeostatic cytokines regulate V\u03b39V\u03b42 T-cell surveillance of mevalonate metabolism.","volume":"3","author":"Gruenbacher","year":"2014","journal-title":"OncoImmunology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature."},{"key":"B84","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1084\/jem.20021500","article-title":"Human T cell receptor \u03b3\u03b4 cells recognize endogenous mevalonate metabolites in tumor cells.","volume":"197","author":"Gober","year":"2003","journal-title":"J Exp Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","article-title":"Microbial isoprenoid biosynthesis and human \u03b3\u03b4 T cell activation.","volume":"544","author":"Eberl","year":"2003","journal-title":"FEBS Lett."},{"key":"B86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","article-title":"Nonpeptide antigens, presentation mechanisms, and immunological memory of human V\u03b32V\u03b42 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens.","volume":"215","author":"Morita","year":"2007","journal-title":"Immunol Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.it.2011.09.007","article-title":"Butyrophilins: an emerging family of immune regulators.","volume":"33","author":"Abeler-D\u00f6rner","year":"2012","journal-title":"Trends Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00251-012-0619-z","article-title":"The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response.","volume":"64","author":"Afrache","year":"2012","journal-title":"Immunogenetics."},{"key":"B89","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","article-title":"Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells.","volume":"14","author":"Vavassori","year":"2013","journal-title":"Nat Immunol."},{"key":"B90","doi-asserted-by":"crossref","first-page":"32780","DOI":"10.1074\/jbc.M112.384354","article-title":"The molecular basis for modulation of human V\u03b39V\u03b42 T cell responses by CD277\/Butyrophilin-3 (BTN3A)-specific antibodies.","volume":"287","author":"Palakodeti","year":"2012","journal-title":"J Biol Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.4049\/jimmunol.1601910","article-title":"The juxtamembrane domain of butyrophilin BTN3A1 controls phosphoantigen-mediated activation of human V\u03b39V\u03b42 T cells.","volume":"198","author":"Peign\u00e9","year":"2017","journal-title":"J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","article-title":"The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells.","volume":"40","author":"Sandstrom","year":"2014","journal-title":"Immunity."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","article-title":"Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset.","volume":"120","author":"Harly","year":"2012","journal-title":"Blood."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/ni.2713","article-title":"CD1d-lipid antigen recognition by the \u03b3\u03b4 TCR.","volume":"14","author":"Uldrich","year":"2013","journal-title":"Nat Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased \u03b3\u03b4 T cells after partially mismatched related donor bone marrow transplantation.","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003501","article-title":"Phosphoantigen\/IL2 expansion and differentiation of V\u03b32V\u03b42 T cells increase resistance to tuberculosis in nonhuman primates.","volume":"9","author":"Chen","year":"2013","journal-title":"PLoS Pathog."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.4049\/jimmunol.1000966","article-title":"Partial and ineffective activation of V\u03b39V\u03b42 T cells by Mycobacterium tuberculosis-infected dendritic cells.","volume":"185","author":"Meraviglia","year":"2010","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.4049\/jimmunol.1602019","article-title":"Adoptive transfer of phosphoantigen-specific \u03b3\u03b4 T cell subset attenuates Mycobacterium tuberculosis infection in nonhuman primates.","volume":"198","author":"Qaqish","year":"2017","journal-title":"J Immunol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030631","article-title":"Clonal immune responses of Mycobacterium-specific \u03b3\u03b4 T cells in tuberculous and non-tuberculous tissues during M. tuberculosis infection.","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050923","article-title":"CD4-CD8-\u03b1\u03b2 and \u03b3\u03b4 T cells display inflammatory and regulatory potentials during human tuberculosis.","volume":"7","author":"Pinheiro","year":"2012","journal-title":"PLoS One."},{"key":"B101","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/eji.200636343","article-title":"A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct \u03b3\u03b4 and \u03b1\u03b2 T cell responses in primates.","volume":"37","author":"Cendron","year":"2007","journal-title":"Eur J Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/cmi.2012.42","article-title":"Mechanisms underlying lineage commitment and plasticity of human \u03b3\u03b4 T cells.","volume":"10","author":"Caccamo","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C.","volume":"391","author":"Braud","year":"1998","journal-title":"Nature."},{"key":"B104","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/eji.201747184","article-title":"Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells.","volume":"48","author":"Prezzemolo","year":"2018","journal-title":"Eur J Immunol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004671","article-title":"Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.","volume":"11","author":"van Meijgaarden","year":"2015","journal-title":"PLoS Pathog."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/eji.201445193","article-title":"Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.","volume":"45","author":"Caccamo","year":"2015","journal-title":"Eur J Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molimm.2020.02.011","article-title":"The unconventional role of HLA-E: the road less traveled.","volume":"120","author":"Grant","year":"2020","journal-title":"Mol Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.vaccine.2019.04.050","article-title":"Harnessing donor unrestricted T-cells for new vaccines against tuberculosis.","volume":"37","author":"Joosten","year":"2019","journal-title":"Vaccine."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.5282\/ubm\/epub.3019","article-title":"The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein.","volume":"149","author":"Ulbrecht","year":"1992","journal-title":"J Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1034\/j.1399-0039.2002.600302","article-title":"Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data.","volume":"60","author":"Grimsley","year":"2002","journal-title":"Tissue Antigens."},{"key":"B111","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases.","volume":"43","author":"Robinson","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000374","article-title":"The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle.","volume":"5","author":"Grotzke","year":"2009","journal-title":"PLoS Pathog."},{"key":"B113","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","article-title":"The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.","volume":"10","author":"Cohen","year":"1999","journal-title":"Immunity."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006384","article-title":"MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.","volume":"13","author":"Bian","year":"2017","journal-title":"PLoS Pathog."},{"key":"B115","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted CD8 T cell responses restricted by major histocompatibility complex E.","volume":"351","author":"Hansen","year":"2016","journal-title":"Science."},{"key":"B116","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection.","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8 T cell epitope recognition paradigms.","volume":"340","author":"Hansen","year":"2013","journal-title":"Science."},{"key":"B118","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine.","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1165\/rcmb.2019-0261OC","article-title":"HLA-E\u2013restricted CD8+ T lymphocytes efficiently control Mycobacterium tuberculosis and HIV-1 coinfection.","volume":"62","author":"La Manna","year":"2020","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","article-title":"Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.","volume":"124","author":"Heczey","year":"2014","journal-title":"Blood."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1172\/JCI83476","article-title":"CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.","volume":"126","author":"Tian","year":"2016","journal-title":"J Clin Invest."},{"key":"B122","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/imcb.12011","article-title":"Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases.","volume":"96","author":"Rouxel","year":"2018","journal-title":"Immunol Cell Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/imcb.12008","article-title":"MAIT cells and viruses.","volume":"96","author":"Ussher","year":"2018","journal-title":"Immunol Cell Biol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2017.07.009","article-title":"MAIT cells in infectious diseases.","volume":"48","author":"Salou","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00262-018-2132-1","article-title":"Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?","volume":"67","author":"Haeryfar","year":"2018","journal-title":"Cancer Immunol Immunother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"p. 1","DOI":"10.1002\/9780470015902.a0020180.pub2","article-title":"CD1d-restricted natural killer T cells.","author":"Hill","year":"2016","journal-title":"eLS."},{"key":"B127","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri797","article-title":"\u03b3\u03b4 T cells: functional plasticity and heterogeneity.","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01401","article-title":"Current advances in \u03b3\u03b4 T cell-based tumor immunotherapy.","volume":"8","author":"Lo Presti","year":"2017","journal-title":"Front Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc3973","article-title":"Evolving synergistic combinations of targeted immunotherapies to combat cancer.","volume":"15","author":"Melero","year":"2015","journal-title":"Nat Rev Cancer."},{"key":"B130","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.4049\/jimmunol.181.10.6707","article-title":"Cutting edge: programmed death-1\/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.","volume":"181","author":"Chang","year":"2008","journal-title":"J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00262-010-0963-5","article-title":"Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.","volume":"60","author":"Durgan","year":"2011","journal-title":"Cancer Immunol Immunother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/eji.201040959","article-title":"Expression and function of PD-1 in human \u03b3\u03b4 T cells that recognize phosphoantigens.","volume":"41","author":"Iwasaki","year":"2011","journal-title":"Eur J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:29:14Z","timestamp":1599143354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":132,"alternative-id":["10.3389\/fimmu.2020.02107"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02107","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"article-number":"2107"}}